Becker's Healthcare May 17, 2024
Paige Twenter

Amgen’s Imdelltra is the first and only T-cell engager therapy approved for extensive-stage small cell lung cancer, an aggressive, stubborn cancer that spreads through the body.

On May 16, the FDA granted Imdelltra an accelerated approval. In a trial with 99 study participants with symptomatic brain metastases,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Will Trump's healthcare appointments bring 'radical changes'?
The Trump picks who want to reform health care

Share This Article